Therapeutic Nutrition With Technology in Primary Care

October 29, 2020 updated by: Jonathan Little, University of British Columbia

Supporting and Enabling Physicians to Deliver Personalized Therapeutic Nutrition Using an Online Technology Platform

Low-carbohydrate diets (less than approximately 130 grams per day) are emerging as an efficacious treatment option with several studies supporting weight loss and remission of type 2 diabetes. Many physicians are now implementing this strategy but the time it takes to educate patients on nutrition is a barrier. The research team is working with physicians to develop a solution whereby the nutrition education and intervention is delivered via mobile/online technology (i.e., an app). This study will test whether it is feasible and efficacious for physicians to recommend this app to their patients with obesity and type 2 diabetes to help them lose weight and improve their condition.

Study Overview

Detailed Description

The study is a non-experimental feasibility study to explore the acceptability, practicality and demand for the use of a 12-week, personalized, online program to teach and coach patients about therapeutic carbohydrate restriction for individuals with obesity and/or at risk for type 2 diabetes/with type 2 diabetes. The program is intended to enhance the usual clinical care provided for patients with these conditions and will allow for physicians to monitor patient progress through the program. Both physician and patient perspectives will be explored.

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Kelowna, British Columbia, Canada, V1V 3G1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals with obesity, at risk for type 2 diabetes or diagnosed with type 2 diabetes interested in therapeutic carbohydrate restriction for management of their condition.

Description

Inclusion Criteria:

  • Overweight or obese (BMI >25 kg/m2)
  • At risk for T2D as deemed by physician
  • Diagnosed with T2D
  • Able to read and speak English (in order to communicate with the technology platform/app
  • Over the age of 18

Exclusion Criteria:

  • Unable to read or speak English (due to the app being provided in English)
  • Unable to access a computer or mobile phone that has access to the internet.
  • Currently compliant with a very low carbohydrate ketogenic diet or very low calorie commercial weight loss program
  • Planning to change doctors in the next 12 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Digital therapeutic carbohydrate restriction (TCR) program
The intervention involves 12 weeks of online/app-based behaviour change coaching. Each week the participant focuses on a different aspect of healthy eating habits designed to cut sugar and refined carbohydrates while encouraging and providing resources for lower-carbohydrate food options. Education is done through short videos and information sheets. Participants set goals and complete worksheets/tasks based on their individual goals.
A 12-week, personalized, online program to teach and coach patients about therapeutic carbohydrate restriction as for obesity and/or T2D (or risk of T2D). The program is intended to enhance the usual clinical care provided for patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The percentage of eligible patients who receive prescriptions to access the online TCR program
Time Frame: through study completion, an average of 9 months
Assessed through the number of voucher cards handed-out over physician documentation of eligible patient visits over the study period.
through study completion, an average of 9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Present descriptive characteristics of patients who get prescriptions to access the online TCR program
Time Frame: through study completion, an average of 9 months
Assessed through program intake collected through the online program (e.g. age, sex, weight, HbA1c, chronic condition, health goals)
through study completion, an average of 9 months
The percentage of patients who receive a prescription for TCR program that sign up and start
Time Frame: through study completion, an average of 9 months
Assessed through the number of voucher cards redeemed on the online program over the number of voucher cards handed-out by physicians.
through study completion, an average of 9 months
Program drop-out as assessed by the number of patients who sign up for and start the TCR program and the number of patients who complete the full program.
Time Frame: Pre-program (month 0) to post-program (6 months)
Assessed through the number of patients enrolled in the program and the number of patients who complete the program through program tracking.
Pre-program (month 0) to post-program (6 months)
Program impact assessed through changes in weight from pre-program to post-program.
Time Frame: Pre-program (month 0) to post-program (6 months)
For patients who complete the program, the change in weight from program sign-up to program completion.
Pre-program (month 0) to post-program (6 months)
Program impact assessed through change in HbA1c from pre-program to post-program.
Time Frame: Pre-program (month 0) to post-program (6 months)
For patients who complete the program, the change in HbA1c from program sign-up to program completion.
Pre-program (month 0) to post-program (6 months)
Program impact assessed through changes in medications from pre-program to post-program.
Time Frame: Pre-program (month 0) to post-program (6 months)
For patients who complete the program, the change in medications from program sign-up to program completion.
Pre-program (month 0) to post-program (6 months)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative patient feedback on program acceptability
Time Frame: Post-program (6 months)
Qualitative semi-structured interviews with patients collecting program feedback on their experiences in the program, specifically asking about the acceptability of the program. Acceptability will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
Post-program (6 months)
Qualitative patient feedback on program practicality
Time Frame: Post-program (6 months)
Qualitative semi-structured interviews with patients collecting program feedback on their experiences in the program, specifically asking about the practicality of the program. Practicality will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
Post-program (6 months)
Qualitative patient feedback on program satisfaction
Time Frame: Post-program (6 months)
Qualitative semi-structured interviews with patients collecting program feedback on their experiences in the program, specifically asking about their satisfaction of the program. Satisfaction will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
Post-program (6 months)
Qualitative physician feedback on program acceptability
Time Frame: through study completion, an average of 9 months
Qualitative semi-structured interviews with physicians collecting feedback on their experiences in the program, specifically asking about the acceptability of the program within their daily physician practice. Acceptability will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
through study completion, an average of 9 months
Qualitative physician feedback on program practicality
Time Frame: through study completion, an average of 9 months
Qualitative semi-structured interviews with physicians collecting feedback on their experiences in the program, specifically asking about the practicality of the program within their daily physician practice. Practicality will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
through study completion, an average of 9 months
Qualitative physician feedback on program satisfaction
Time Frame: through study completion, an average of 9 months
Qualitative semi-structured interviews with physicians collecting feedback on their experiences in the program, specifically asking about the satisfaction of the program within their daily physician practice. Satisfaction will be assessed through the audio-recorded responses to semi-structured interview questions, subsequently transcribed and coded using content analysis.
through study completion, an average of 9 months
Characteristics of individuals who drop-out of program
Time Frame: through study completion, an average of 9 months
Provide descriptive statistics (e.g. age, sex, weight, HbA1c, chronic condition, health goals) of individuals who drop-out after enrolling in the program and prior to program completion.
through study completion, an average of 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jonathon Little, PhD, The University of British Columbia, Okanagan Campus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2020

Primary Completion (Anticipated)

September 15, 2021

Study Completion (Anticipated)

September 30, 2021

Study Registration Dates

First Submitted

October 8, 2020

First Submitted That Met QC Criteria

October 29, 2020

First Posted (Actual)

November 5, 2020

Study Record Updates

Last Update Posted (Actual)

November 5, 2020

Last Update Submitted That Met QC Criteria

October 29, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • H19-00316

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet Modification

Clinical Trials on Digital therapeutic carbohydrate restriction (TCR) program

3
Subscribe